MedPath

北京万辉双鹤药业有限责任公司

Ownership
-
Established
1973-08-01
Employees
-
Market Cap
-
Website
http://www.whdcpc.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

84

NMPA:84

Drug Approvals

败酱片

Approval Number
国药准字Z11020693
Approval Date
Dec 30, 2024
NMPA

新碧桃仙片

Approval Number
国药准字Z11021074
Approval Date
Dec 30, 2024
NMPA

昆明山海棠片

Approval Number
国药准字Z11021073
Approval Date
Dec 30, 2024
NMPA

康尔心胶囊

Approval Number
国药准字Z11020685
Approval Date
Dec 30, 2024
NMPA

金莲花片

Approval Number
国药准字Z11021083
Approval Date
Dec 30, 2024
NMPA

小儿清解颗粒

Approval Number
国药准字Z11020688
Approval Date
Dec 25, 2024
NMPA

复方百部止咳颗粒

Approval Number
国药准字Z11020682
Approval Date
Dec 25, 2024
NMPA

Naproxen Tablets

Product Name
萘普生片
Approval Number
国药准字H11021202
Approval Date
Nov 14, 2023
NMPA

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H11021284
Approval Date
Nov 14, 2023
NMPA

Ampicillin Granules

Product Name
氨苄西林颗粒
Approval Number
国药准字H11021977
Approval Date
Nov 14, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.